can probiotics reduce the inflammation in acute coronary syndrome patients
Phase 3
- Conditions
- Health Condition 1: null- ACUTE CORONARY SYNDROME
- Registration Number
- CTRI/2017/06/008802
- Lead Sponsor
- R and D Department of NEXTGEN PHARMA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 312
Inclusion Criteria
PATIENTS WITH ACUTE CORONARY SYNDROME
Exclusion Criteria
Acute coronary syndrome patients who also will have the following conditions
1.Atrial flutter,
2.Atrial fibrillation,
3.Bundle branch block(BBB)
4.Dilated cardiomyopathy
5.Valvular heart disease
6.Malignancy
7.Chronic inflammatory conditions like
a)Systemic lupus erythmatosis
b)Rheumatoid Arthritis
c)Ulcerative colitis
d)Ankylosing spondylitis and others affecting the study markers.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method